Cimivir-L Tablet is a combination of antiviral medicine to treat chronic hepatitis C viral infection of the liver in adults and pediatric patients 3 years of age and older. Cimivir-L Tablet helps your immune system fight the infection and may help your liver recover.
Cimivir-L Tablet may cause some common side effects such as weakness, headache or tired feeling. If you experience any of these symptoms while taking Cimivir-L Tablet stop taking the medication, and you should consult your doctor right away.
Before taking Cimivir-L Tablet talk to your doctor about the potential risks and benefits of taking this medication, as well as any other questions or concerns you may have and also important to let your doctor you have any pre-existing diseases or using any medications, vitamins supplements, herbal medicine you are taking.
Cimivir-L Tablet should be taken with or without food daily once daily. It is important to follow your doctor's instructions for taking Cimivir-L Tablet to continue taking the medication as prescribed even if you feel well. Do not stop taking Cimivir-L or change your dosage without first consulting your doctor.
Chronic Hepatitis-C Infection: Cimivir-L Tablet is used to treat chronic hepatitis C a viral infection of the liver in adults and pediatric patients 3 Years of age and older. The signs and symptoms include bleeding easily, bruising easily, fatigue, poor appetite, yellow discolouration of the skin and eyes (jaundice), dark-coloured urine, itchy skin, etc.
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Cimivir-L Tablet reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.
Cimivir-L Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Cimivir-L Tablet may take with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Cimivir-L Tablet is combined of two antiviral medicines called Velpatasvir and Sofosbuvir. Cimivir-L Tablet is a combination of two drugs, sofosbuvir and LedipasvirCimivir-L works by lowering the amount of virus in the body and gradually eliminating it.
Cimivir-L Tablet is safe to use in patients with mild to moderate kidney disease. No dose adjustment of Cimivir-L Tablet is recommended. If you suffering from severe kidney disease caution should be advised while taking Cimivir-L.
Cimivir-L Tablet may be considered safe for use during pregnancy if the potential benefits outweigh the potential risks to the fetus. This determination is based on animal studies which have revealed minimal to no harm to the developing fetus, although human studies on its effects during pregnancy are limited.
The use of Cimivir-L while breastfeeding is likely safe, as limited human data suggests that it does not pose a significant risk to the infant.
Cimivir-L Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Cimivir-L.
It is generally not recommended to drink alcohol while taking Cimivir-L Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Cimivir-L Tablet is safe to use in patients with liver disease. No dose adjustment of Cimivir-L is recommended. If you experience any side effects please consult your doctor.
1. Harvonitm (ledipasvir And Sofosbuvir) Tablets, For Oral Use, Gilead Sciences, Inc. Product Leaflet
2. Ledipasvir/sofosbuvir, 90mg/400mg, Film-coated Tablet (harvoni, Scottish Medicines Consortium: Smc,gilead Sciences Ltd, Available Form
3. Ledipasvir And Sofosbuvir Tablet, Film Coated, Dailymed. Available Form
4. Ledipasvir And Sofosbuvir, Drugs.com. Avaliable Form